These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28854405)

  • 1. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
    Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
    Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
    Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
    Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F; Bragazzi NL; Nardone R; Trinka E
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
    Zhang L; Li S; Li H; Zou X
    Seizure; 2016 Jul; 39():28-33. PubMed ID: 27236448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
    Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C
    Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
    Gao L; Xia L; Zhao FL; Li SC
    Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.
    Otoul C; Arrigo C; van Rijckevorsel K; French JA
    Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
    Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
    Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
    Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
    Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J
    Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis.
    Hu Q; Zhang F; Teng W; Hao F; Zhang J; Yin M; Wang N
    J Neurol; 2018 Jan; 265(1):1-11. PubMed ID: 28940083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
    Kim JH; Lee SK; Loesch C; Namgoong K; Lee HW; Hong SB;
    Epilepsia; 2017 Apr; 58(4):e70-e74. PubMed ID: 28395124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
    Ben-Menachem E; Mameniškienė R; Quarato PP; Klein P; Gamage J; Schiemann J; Johnson ME; Whitesides J; McDonough B; Eckhardt K
    Neurology; 2016 Jul; 87(3):314-23. PubMed ID: 27335114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
    Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
    Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
    Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
    Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
    Shorvon SD; Löwenthal A; Janz D; Bielen E; Loiseau P
    Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.